SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will sit on a panel titled "Getting the Funds You Need to Build and Grow Your Company" at the Specialty Pharmaceutical Conference sponsored by the Institute for International Research in Orlando.
News | 04. 11. 2007
